MORRIS PLAINS, N.J., Sept. 12, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, is scheduled to present at the 2011 UBS Global Life Sciences Conference on Monday, September 19th at 8:00 a.m. Eastern time at the Grand Hyatt Hotel in New York City. The presentation, which can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf, will provide a corporate overview.
